Purpose Specialty medications can have life-altering outcomes for patients with complex
diseases. However, their benefit relies on appropriate treatment selection, patients' ability to …

BACKGROUND: Multiple sclerosis (MS) is chronic progressive disease that poses a
significant economic burden to patients and health care systems in the United States. We …

Health disparity is defined as a type of health difference that is closely linked with social,
economic and/or environmental disadvantage. Over the past two decades, major efforts …

We estimate the causal effects of drug copayment coupons, which reduce consumer cost-
sharing for branded prescription drugs, on net-of-rebate price and quantities sold. Focusing …

OBJECTIVES: Patient assistance programs (eg, co-pay assistance) may reduce patients' out-
of-pocket costs for prescription medicines, providing financial assistance to access …

BACKGROUND: Specialty drugs are identified by high monthly costs and complexity of
administration. Payers use utilization management strategies, including prior authorization …

Background: To better address their patients' needs, community pharmacists are expanding
from their traditional role of dispensing to managing medications and providing other care …

Purpose This study evaluated patient-reported outcomes (PROs) and pharmacist actions for
patients on disease-modifying therapies (DMTs) for multiple sclerosis (MS) through health …

Purpose The results of the 2022 American Society of Health-System Pharmacists (ASHP)
Survey of Health-System Specialty Pharmacy (HSSP) Practice: Practice Models, Operations …

Background Though there are several disease-modifying therapy (DMT) options for patients
with multiple sclerosis (MS), treatment outcomes rely on patient adherence and persistence …